SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-029242
Filing Date
2016-11-14
Accepted
2016-11-14 16:02:25
Documents
65
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 CLSD-10-Q-20160930 clsd-10q_20160930.htm 10-Q 1769962
2 EX-31.1 clsd-ex311_7.htm EX-31.1 15288
3 EX-31.2 clsd-ex312_6.htm EX-31.2 15283
4 EX-32.1 clsd-ex321_8.htm EX-32.1 9017
  Complete submission text file 0001564590-16-029242.txt   5827829

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clsd-20160930.xml EX-101.INS 1130475
6 XBRL TAXONOMY EXTENSION SCHEMA clsd-20160930.xsd EX-101.SCH 47123
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20160930_cal.xml EX-101.CAL 47313
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20160930_def.xml EX-101.DEF 147729
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20160930_lab.xml EX-101.LAB 355869
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20160930_pre.xml EX-101.PRE 260135
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 161994690
SIC: 2834 Pharmaceutical Preparations